Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities
Andreas Sutter(Bayer (Germany)), Alexander Amberg(Sanofi (Germany)), Scott Boyer(AstraZeneca (Sweden)), Alessandro Brigo(Roche (Switzerland)), Joseph F. Contrera, Laura Custer(Bristol-Myers Squibb (United States)), Krista L. Dobo(Pfizer (United States)), Véronique Gervais(Servier (France)), Susanne Glowienke(Novartis Institutes for BioMedical Research), Jacky Van Gompel(Janssen (Belgium)), Nigel Greene(Pfizer (United States)), Wolfgang Muster(Roche (Switzerland)), John Nicolette(Abbott (United States)), M. Vijayaraj Reddy(United States Military Academy), Véronique Thybaud(Sanofi (France)), Esther Vock(Boehringer Ingelheim (Germany)), Angela White, Lutz Müller(Roche (Switzerland))
Cited by 126
Abstract
Related Papers
No related papers found
Powered by citation graph analysis